Anebulo Pharmaceuticals, Inc. (ANEB)
OTCMKTS · Delayed Price · Currency is USD
0.4780
+0.0030 (0.63%)
Jun 15, 2026, 9:31 AM EST
Anebulo Pharmaceuticals Market Cap
Anebulo Pharmaceuticals has a market cap or net worth of $19.48 million as of June 16, 2026. Its market cap has decreased by -54.85% in one year.
Market Cap
19.48M
Enterprise Value
10.44M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.48
Market Cap Chart
Since May 7, 2021, Anebulo Pharmaceuticals's market cap has decreased from 165.19M to 19.48M, a decrease of -88.21%. That is a compound annual growth rate of -34.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 19.48M | -53.06% |
| Dec 31, 2025 | 41.50M | -4.76% |
| Dec 31, 2024 | 43.57M | -29.77% |
| Dec 29, 2023 | 62.03M | -0.15% |
| Dec 30, 2022 | 62.13M | -56.73% |
| Dec 29, 2021 | 143.57M | -13.09% |
| May 7, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Provectus Biopharmaceuticals | 26.21M |
| EOM Pharmaceuticals Holdings | 25.30M |
| Arch Biopartners | 23.98M |
| NKGen Biotech | 19.59M |
| Oncotelic Therapeutics | 17.74M |
| ZIVO Bioscience | 15.32M |
| Inhibitor Therapeutics | 14.75M |
| Galera Therapeutics | 13.97M |